Experimental immune cell therapy for transplant viruses shows early promise but study halted

This early-stage trial tested whether specially grown immune cells could help transplant patients fight off stubborn viral infections. The study included 8 people who had received a stem cell or organ transplant and had ongoing infections with adenovirus, CMV, or EBV. The approach aimed to boost the body's defenses without the long wait and high cost of personalized treatments. The study was terminated early, so results are limited.